Chromatographic techniques in analysis of cyclooxygenase-2 inhibitors in drugs and biological samples

被引:4
作者
Starek, Malgorzata [1 ]
Dabrowska, Monika [1 ]
机构
[1] Jagiellonian Univ, Dept Inorgan & Analyt Chem, Coll Med, Fac Pharm, PL-30688 Krakow, Poland
来源
CENTRAL EUROPEAN JOURNAL OF CHEMISTRY | 2012年 / 10卷 / 03期
关键词
COX-2; inhibitors; Analysis; Chromatography; Stability; Pharmacokinetic; PERFORMANCE LIQUID-CHROMATOGRAPHY; ULTRAVIOLET ABSORBENCY DETECTION; PROCESS-RELATED IMPURITIES; INDICATING HPLC METHOD; HUMAN PLASMA; MASS-SPECTROMETRY; BULK DRUG; DEGRADATION-PRODUCTS; SELECTIVE INHIBITOR; COX-2; INHIBITOR;
D O I
10.2478/s11532-012-0029-y
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Non-steroidal anti-inflammatory drugs, as a therapeutic class, are among the most often used active pharmaceutical ingredients in heath care in the world. They are mostly available without prescription and often used for treatment of fever and pain. An extensive research of the literature published in analytical and pharmaceutical chemistry journals has been conducted and the chromatographic methods which were used for the purity, stability and pharmacokinetic studies of the cyclooxygenase-2 inhibitors, in formulations and biological materials have been reviewed. The methodology for the analysis of selected drugs is very well documented and many examples are available in the literature. The common use of chromatographic techniques with various detection attachments provide possibility for monitoring of drugs in therapy.
引用
收藏
页码:711 / 730
页数:20
相关论文
共 77 条
[41]   An overview of the recent developments in analytical methodologies for determination of COX-2 inhibitors in bulk drugs, pharmaceuticals and biological matrices [J].
Rao, RN ;
Meena, S ;
Rao, AR .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2005, 39 (3-4) :349-363
[42]   Forced-degradation study of valdecoxib as bulk drug and in tablet formulation by HPTLC [J].
Ravi, thengungal Kochupappy ;
Gandhimathi, Muruganathan ;
Suganthi, Azhewar ;
Sarovar, Sabitha .
JOURNAL OF SEPARATION SCIENCE, 2006, 29 (11) :1647-1652
[43]   Isolation and characterisation of process-related impurities in rofecoxib [J].
Reddy, KVSRK ;
Babu, JM ;
Dubey, PK ;
Sekhar, BC ;
Reddy, GO ;
Vyas, K .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2002, 29 (1-2) :355-360
[44]  
Riendeau D, 2001, J PHARMACOL EXP THER, V296, P558
[45]   Simultaneous determination of unlabeled and carbon-13-labeled etoricoxib, a new cyclooxygenase-2 inhibitor, in human plasma using HPLC-MS/MS [J].
Rose, MJ ;
Agrawal, N ;
Woolf, EJ ;
Matuszewski, BK .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2002, 91 (02) :405-416
[46]   Simultaneous detection and quantification of parecoxib and valdecoxib in canine plasma by HPLC with spectrofluorimetric detection: development and validation of a new methodology [J].
Saccomanni, G. ;
Giorgi, M. ;
Del Carlo, S. ;
Manera, C. ;
Saba, A. ;
Macchia, M. .
ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2011, 401 (05) :1677-1684
[47]   HPLC determination and pharmacokinetic study of valdecoxib in human plasma [J].
Sane, RT ;
Menon, S ;
Deshpande, AY ;
Jain, A .
CHROMATOGRAPHIA, 2005, 61 (3-4) :137-141
[48]   Isolation, synthesis and characterization of impurities in Celecoxib a cox-2 inhibitor [J].
Satyanarayana, U ;
Rao, DS ;
Kumar, YR ;
Babu, JM ;
Kumar, PR ;
Reddy, JT .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2004, 35 (04) :951-957
[49]   Validation of an HPLC method for the determination of valdecoxib and its degradation product:: a mixture of α- and β-n-lactosyl sulfonamide anomers [J].
Savic, G. ;
Zecevic, M. ;
Jocic, B. ;
Zivanovic, Lj. .
CHROMATOGRAPHIA, 2007, 66 (1-2) :29-35
[50]   Simple and sensitive method for the determination of celecoxib in human serum by high-performance liquid chromatography with fluorescence detection [J].
Schönberger, F ;
Heinkele, G ;
Mürdter, TE ;
Brenner, S ;
Klotz, U ;
Hofmann, U .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2002, 768 (02) :255-260